Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma
Clinical trial NCT07520214 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07520214
- Sponsor
- Beijing Neurosurgical Institute
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-10
- Primary completion
- 2027-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.